Bxos110
AIS
Biocells (Beijing) Biotech Co.,LtdPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the AIS cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nbp CSPC-NBP Pharmaceutical Co., Ltd. | Phase 2 | B |
Same molecule, other indications
Bxos110 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →